However, colorectal cancer, malignant salivary gland tumor, and chromophobe cell carcinoma patients with high expression of PD-L2 showed poor prognostic outcomes (Danilova et al. 2016; Obeid et al. 2016; Steuer et al. 2018). This evidence concerns the gene PDCD1LG2 and colorectal cancer.